Exalys Therapeutics is developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range of diseases with urgent unmet needs and limited treatment options.

Biotechnology

Education

Exalys Therapeutics

Rick Orr

Shashidhar Kori

Lynne Rollins

William Martin

Julien Mamet

David Yeomans

Dennis Podlesak

Colm Cunningham

Eckard Weber

William Schmidt

BT Slingsby

Nicole Vitullo

Takeshi Takahashi

Donald Manning

The Executive Management team at Exalys Therapeutics spearheads the strategic direction and overall vision of the company. This team is responsible for corporate governance, scientific and medical oversight, financial stewardship, and operational management, ensuring that Exalys delivers groundbreaking anti-inflammatory treatments to address critical medical needs.

Executive Management

The Leadership Team at Exalys Therapeutics drives the strategic vision and operational excellence of the company, ensuring the development of innovative anti-inflammatory therapeutics. Comprised of experts in science, medicine, finance, and corporate development, the team collaboratively guides decision-making, resource allocation, and partnerships to address urgent medical needs and enhance therapeutic outcomes.

Leadership Team

The Advisory Team at Exalys Therapeutics provides strategic guidance and expert insights to drive the development of innovative anti-inflammatory therapeutics. Comprised of experienced advisors, the team plays a crucial role in shaping research directions, optimizing clinical strategies, and ensuring that the company's initiatives align with industry standards and unmet medical needs.

Advisory Team

Exalys Therapeutics

Org chart

Board & advisors

Teams

Executive Management

Leadership Team

Advisory Team

Offices

Exalys Therapeutics

Org chart

Board & advisors

Teams

Executive Management

Leadership Team

Advisory Team

Offices

Related companies